Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases

Author： Erovigni Francesco   Gambino Alessio   Cabras Marco   Fasciolo Antonella   Bianchi Silvio Diego   Bellini Elisa   Fusco Vittorio  

Publisher： MDPI

E-ISSN： 2304-6767|4|4|39-39

ISSN： 2304-6767

Source： Dentistry Journal, Vol.4, Iss.4, 2016-10, pp. : 39-39

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition

By Migliario Mario   Mergoni Giovanni   Vescovi Paolo   De Martino Iolanda   Alessio Manuela   Benzi Luca   Renò Filippo   Fusco Vittorio  

Dentistry Journal, Vol. 5, Iss. 1, 2017-03 ,pp. : 13-13

MDPI

Access to resources Recommend Favorite

Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures

By Catania Gioacchino   Monaco Federico   Limberti Giulia   Alessio Manuela   De Martino Iolanda   Barile Cecilia   Fasciolo Antonella   Baraldi Anna   Ladetto Marco   Fusco Vittorio  

Dentistry Journal, Vol. 4, Iss. 4, 2016-12 ,pp. : 45-45

MDPI

Access to resources Recommend Favorite

Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma

By Rugani Petra   Walter Christian   Kirnbauer Barbara   Acham Stephan   Begus-Nahrman Yvonne   Jakse Norbert  

Dentistry Journal, Vol. 4, Iss. 4, 2016-09 ,pp. : 32-32

MDPI

Access to resources Recommend Favorite

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

By  

Chemotherapy, Vol. 57, Iss. 2, 2011-03 ,pp. : 138-144

Karger

Access to resources Recommend Favorite

Patients with Metastatic Colorectal Cancer and Hyperbilirubinemia Treated with FOLFIRI plus Bevacizumab as First-Line Treatment

By  

Chemotherapy, Vol. 62, Iss. 1, 2016-09 ,pp. : 80-84

Karger

Access to resources Recommend Favorite